Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Olympus y W. L. Gore & Associates han suscrito un Contrato de distribución internacional para ampliar la gama de dispositivos EndoTherapy de Olympus
  • Japan - Japanese
  • USA - Français
  • USA - Italiano
  • USA - Deutsch
  • APAC - English
  • APAC - Traditional Chinese
  • USA - English
  • USA - English

Olympus_Logo

News provided by

Olympus

Oct 06, 2025, 03:00 ET

Share this article

Share toX

Share this article

Share toX

CENTER VALLEY, Pa., y HAMBURGO, 6 de octubre de 2025 /PRNewswire/ -- Olympus Corporation, una compañía de tecnología médica internacional comprometida con hacer que la vida de las personas sea más sana, segura y satisfactoria, ha suscrito un contrato de distribución internacional con la unidad de negocio de productos sanitarios de W. L. Gore & Associates, Inc. (en lo sucesivo Gore) con sede en EE. UU., es una compañía internacional de ciencias de materiales que desarrolla productos innovadores en diversas industrias. El contrato permite a Olympus pasar a ser el distribuidor internacional exclusivo y tener los derechos de distribución de las endoprótesis biliares GORE® VIABIL® para colocación endoscópica. Olympus comenzará con la comercialización en los próximos meses, comenzando en Europa y ampliándose gradualmente a otros países con el tiempo. La incorporación de la endoprótesis biliar GORE® VIABIL® para colocación endoscópica en su portafolio hepato-pancreato-biliar (HPB) permitirá a Olympus expandir su presencia global en el mercado de stents metálicos gastrointestinales (GI), que está creciendo rápidamente.

Continue Reading
GORE® VIABIL® Biliary Endoprosthesis
GORE® VIABIL® Biliary Endoprosthesis

La asociación de Gore y Olympus permite reunir talento y tecnología, y el presente acuerdo presenta oportunidades para elevar el nivel de la atención, ya que ambas empresas comparten un historial de suministro de productos terapéuticos intervencionistas innovadores para mejorar los resultados para los pacientes. Con la incorporación de la endoprótesis biliar GORE® VIABIL® para la colocación endoscópica a su gama existente de stents diseñada para el árbol biliar, Olympus ofrece a los profesionales sanitarios y a sus pacientes una amplia gama de dispositivos GI.

La endoprótesis biliar GORE® VIABIL® para colocación endoscópica es un stent metálico autoexpandible completamente cubierto que ofrece una alternativa diferenciada para aliviar los síntomas asociados a las estenosis biliares.* El sistema de suministro fácil de usar y el diseño no retráctil† permite la implantación de forma precisa. La endoprótesis biliar GORE® VIABIL® para colocación endoscópica incorpora un revestimiento no poroso de ePTFE/FEP (polietileno tetrafluoroetileno expandido/etileno propileno fluorado) que crea una barrera fuerte y duradera que proporciona la ventaja de un stent cubierto que previene el crecimiento interno del tumor, sin aumentar la tasa de migración que suele verse para stents cubiertos.1,2,3,4

"Estamos emocionados por colaborar con Gore como líder global en tecnologías innovadoras. El stent VIABIL es un dispositivo crítico para la atención de los pacientes gastrointestinales, y este acuerdo complementará nuestra gama de CPRE líder del sector ", dijo Mike Callaghan, Vicepresidente global/Director general de EndoTherapy para Olympus. "Olympus se ha comprometido a ayudar a las organizaciones sanitarias y a los profesionales médicos a ofrecer cuidados de primera calidad a sus pacientes, y la relación con Gore es un paso importante para conseguir ese objetivo."

"Gore tiene el orgullo de asociarse con Olympus. Creemos firmemente que la destreza comercial demostrada de nuestro equipo EndoTherapy de Olympus será el complemento perfecto para la experiencia en innovación de dispositivos médicos de Gore para servir mejor a los pacientes con soluciones únicas en el futuro", dijo Jake Goble, Responsable de la unidad de negocio de Soluciones quirúrgicas y cardiacas de Gore.

* Existen diferencias regionales en el uso previsto. Consulte siempre las Instrucciones de uso para obtener información completa sobre las indicaciones, contraindicaciones e información de seguridad relevante en su región.
† Si se implanta de la forma indicada, la endoprótesis no se escorzará de forma visible.

1. Brown MA. Biliary Fully Covered Metal Stents: Systematic Review of the Clinical Literature. W. L. Gore & Associates, Flagstaff, AZ; 2019. [Work plan]. WP111272. Attachment 1: Literature Appraisal for Viabil, Attachment 2: Literature Appraisal for Other Fully Covered Biliary Stents (FCBS), Attachment 3: Migration Rate Comparison.
2. Guzmán-Calderón GE, Chirinos J, Díaz-Arocutipa C, et al. Covered Versus Uncovered Metal Stents for the Drainage of the Malignant Distal Biliary Obstruction With ERCP: A Systematic Review and Meta-Analysis. Journal of Clinical Gastroenterology 2025;59(3):276-284.
3. Krokidis M, Fanelli F, Orgera G, et al. Percutaneous treatment of malignant jaundice due to extrahepatic cholangiocarcinoma: covered Viabil stent versus uncovered Wallstents. Cardiovascular & Interventional Radiology 2010;33(1):97-106.
4. Krokidis M, Fanelli F, Orgera G, et al. Percutaneous palliation of pancreatic head cancer: randomized comparison of ePTFE/FEP-covered versus uncovered nitinol biliary stents. Cardiovascular & Interventional Radiology 2011;34(2):352-361. 

Acerca de Olympus

En Olympus, estamos comprometidos con Nuestro Propósito de hacer que la vida de las personas sea más saludable, segura y satisfactoria. Como empresa global de tecnología médica colaboramos estrechamente con profesionales de la salud para ofrecer las innovadores soluciones y servicios para la detección precoz, el diagnóstico y el tratamiento mínimamente invasivo de enfermedades. Nuestro objetivo es mejorar los resultados clínicos de nuestros pacientes elevando el estándar de atención en determinadas patologías.

Durante más de 100 años, Olympus ha trabajado con el fin de contribuir a la sociedad fabricando los productos que mejor satisfacen las necesidades de los clientes de todo el mundo.

Olympus Europa, con sede en Hamburgo, Alemania, da servicio a la región de EMEA (Europa, Oriente Medio y África) y emplea a 7600 personas en 29 países. Para más información, visite www.olympus-europa.com y siga nuestra cuenta de LinkedIn: www.linkedin.com/company/olympus-corp.

Acerca de Gore

W. L. Gore & Associates es una compañía internacional de ciencias de materiales dedicada a transformar las industrias y mejorar las vidas. Desde 1958, Gore ha resuelto desafíos técnicos muy complejos en entornos exigentes como el espacio exterior o los picos más altos del mundo y trabajos internos en el cuerpo humano. Con aproximadamente 13.000 asociados y una cultura orientada al trabajo en equipo, Gore genera unos ingresos anuales de 5 mil millones de dólares. Para más información, visite gore.com.

Foto - https://mma.prnewswire.com/media/2788798/GORE_VIABIL_Biliary_Endoprosthesis.jpg 

Logo - https://mma.prnewswire.com/media/1774929/Olympus_Logo.jpg

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Olympus and W. L. Gore & Associates passe un accord de distribution internationale pour développer la gamme EndoTherapy d'Olympus

Olympus and W. L. Gore & Associates passe un accord de distribution internationale pour développer la gamme EndoTherapy d'Olympus

Olympus Corporation, une entreprise internationale des technologies médicales dédiée à rendre la vie des autres plus saine, plus sûre et plus...

Olympus e W. L. Gore & Associates stipulano un accordo di distribuzione internazionale per ampliare il portfolio EndoTherapy di Olympus

Olympus e W. L. Gore & Associates stipulano un accordo di distribuzione internazionale per ampliare il portfolio EndoTherapy di Olympus

Olympus Corporation, azienda globale del settore MedTech dedicata a rendere la vita delle persone più salutare, sicura e gratificante, ha stipulato...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Licensing

Licensing

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.